Package | hl7.fhir.uv.pddi |
Type | ValueSet |
Id | valueset-rimexolone-exclude |
FHIR Version | R4 |
Source | http://hl7.org/fhir/uv/pddi/https://build.fhir.org/ig/HL7/PDDI-CDS/ValueSet-valueset-rimexolone-exclude.html |
URL | http://hl7.org/fhir/uv/pddi/ValueSet/valueset-rimexolone-exclude |
Version | 1.0.0-ballot |
Status | draft |
Date | 2018-07-02 |
Name | Valueset_rimexolone_exclude |
Title | Exclude Rimexolone Medications Value Set |
Realm | uv |
Authority | hl7 |
Description | ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations. |
Purpose | To refine valueset for Warfarin + NSAID PDDI-CDS |
Copyright | (copyright expectations unknown) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
rxnorm | RxNorm |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet valueset-rimexolone-exclude
http://www.nlm.nih.gov/research/umls/rxnorm
Code | Display |
207446 | rimexolone 10 MG/ML Ophthalmic Suspension [Vexol] |
365826 | rimexolone Ophthalmic Suspension [Vexol] |
199115 | rimexolone 10 MG/ML Ophthalmic Suspension |
379299 | rimexolone Ophthalmic Suspension |
1157440 | rimexolone Ophthalmic Product |
1188083 | Vexol Ophthalmic Product |
{ "resourceType": "ValueSet", "id": "valueset-rimexolone-exclude", "text": { "status": "generated", "div": "<!-- snip (see above) -->" }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg", "valueCode": "cds" } ], "url": "http://hl7.org/fhir/uv/pddi/ValueSet/valueset-rimexolone-exclude", "version": "1.0.0-ballot", "name": "Valueset_rimexolone_exclude", "title": "Exclude Rimexolone Medications Value Set", "status": "draft", "experimental": true, "date": "2018-07-02", "publisher": "HL7 Clinical Decision Support Workgroup", "contact": [ { "telecom": [ { "system": "url", "value": "http://hl7.org/Special/committees/dss" } ] } ], "description": "ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.", "jurisdiction": [ { "coding": [ { "system": "http://unstats.un.org/unsd/methods/m49/m49.htm", "code": "001" } ] } ], "purpose": "To refine valueset for Warfarin + NSAID PDDI-CDS", "copyright": "(copyright expectations unknown)", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "207446", "display": "rimexolone 10 MG/ML Ophthalmic Suspension [Vexol]" }, { "code": "365826", "display": "rimexolone Ophthalmic Suspension [Vexol]" }, { "code": "199115", "display": "rimexolone 10 MG/ML Ophthalmic Suspension" }, { "code": "379299", "display": "rimexolone Ophthalmic Suspension" }, { "code": "1157440", "display": "rimexolone Ophthalmic Product" }, { "code": "1188083", "display": "Vexol Ophthalmic Product" } ] } ] } }